Details of the Drug
General Information of Drug (ID: DMG1ATX)
Drug Name |
[(1e)-4-Phenylbut-1-Enyl]Benzene
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
[(1E)-4-PHENYLBUT-1-ENYL]BENZENE; 1,4-DIPHENYL-1-BUTENE; 14213-84-4; AC1NR9PT; (E)-1,4-Diphenyl-1-butene; [(E)-4-phenylbut-1-enyl]benzene; ZINC14880527; [(1E)-4-phenyl-1-butenyl]benzene; [(E)-4-phenyl-but-1-enyl]-benzene; 1,1'-(1E)-but-1-ene-1,4-diyldibenzene
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 208.3 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 4.8 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 0 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References